Abstract

Resistant mouse strains mount a protective T cell-mediated immune response upon infection with Leishmania (L.) parasites. Healing correlates with a T helper (Th) cell-type 1 response characterized by a pronounced IFN-γ production, while susceptibility is associated with an IL-4-dependent Th2-type response. It has been shown that dermal dendritic cells are crucial for inducing protective Th1-mediated immunity. Additionally, there is growing evidence that C-type lectin receptor (CLR)-mediated signaling is involved in directing adaptive immunity against pathogens. However, little is known about the function of the CLR Dectin-1 in modulating Th1- or Th2-type immune responses by DC subsets in leishmaniasis. We characterized the expression of Dectin-1 on CD11c+ DCs in peripheral blood, at the site of infection, and skin-draining lymph nodes of L. major-infected C57BL/6 and BALB/c mice and in peripheral blood of patients suffering from cutaneous leishmaniasis (CL). Both mouse strains responded with an expansion of Dectin-1+ DCs within the analyzed tissues. In accordance with the experimental model, Dectin-1+ DCs expanded as well in the peripheral blood of CL patients. To study the role of Dectin-1+ DCs in adaptive immunity against L. major, we analyzed the T cell stimulating potential of bone marrow-derived dendritic cells (BMDCs) in the presence of the Dectin-1 agonist Curdlan. These experiments revealed that Curdlan induces the maturation of BMDCs and the expansion of Leishmania-specific CD4+ T cells. Based on these findings, we evaluated the impact of Curdlan/Dectin-1 interactions in experimental leishmaniasis and were able to demonstrate that the presence of Curdlan at the site of infection modulates the course of disease in BALB/c mice: wild-type BALB/c mice treated intradermally with Curdlan developed a protective immune response against L. major whereas Dectin-1−/− BALB/c mice still developed the fatal course of disease after Curdlan treatment. Furthermore, the vaccination of BALB/c mice with a combination of soluble L. major antigens and Curdlan was able to provide a partial protection from severe leishmaniasis. These findings indicate that the ligation of Dectin-1 on DCs acts as an important checkpoint in adaptive immunity against L. major and should therefore be considered in future whole-organism vaccination strategies.

Highlights

  • Cutaneous leishmaniasis (CL) is a vector-borne parasitic infectious disease encountered in tropical and subtropical regions of the world [1]

  • Based on the potential role of Dectin-1+ DCs in adaptive immunity, we addressed the question whether a cutaneous infection with Leishmania parasites results in an expansion of Dectin-1+ DCs

  • Other groups demonstrated that an i.v. immunization with β-glucans combined with killed parasites induced a reduction in the parasite load in visceral organs of BALB/c and C57BL/6 mice [46, 109] and that CF-1 mice developed a milder course of visceral leishmaniasis (VL), if they had been pretreated s.c. or i.v. with β-glucans in combination with killed L. donovani parasites [43, 110]

Read more

Summary

Introduction

Cutaneous leishmaniasis (CL) is a vector-borne parasitic infectious disease encountered in tropical and subtropical regions of the world [1]. Different clinical manifestations in humans, ranging from a self-limiting cutaneous infection to disseminating visceral leishmaniasis (VL), are described with respect to the transmitting vectors and Leishmania species [2]. Comparable to the course of disease in humans, L. major parasites can develop cutaneous manifestations in C57BL/6 and BALB/c mouse models [3]. It is known that L. major parasites require phagocytic cells for replication and spreading within the host [4]. In this regard, neutrophils and macrophages play a pivotal role as host cells for the initial survival and spreading of parasites. CD4+ T cells are crucial key players in modulating antigen-specific immunity in leishmaniasis [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call